Blood SCIE

国际简称：BLOOD 参考译名：血液

主要研究方向：医学-血液学非预警期刊审稿周期：约1.0个月

《血液》(Blood)是一本由American Society of Hematology出版的以医学-血液学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

1区中科院分区
Q1 JCR分区
379 年发文量
21 IF影响因子
未开放 是否OA
426 H-index
1946 创刊年份
Semimonthly 出版周期
English 出版语言

Blood, the official journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.

Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy scope; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate. Authors are invited to contact the Editor-in-Chief prior to submission if they are uncertain whether their work falls within the general scope of the journal.

[ 查看全部 ]

投稿咨询加急咨询

Blood期刊信息

ISSN：0006-4971
出版语言：English
是否OA：未开放
E-ISSN：1528-0020
出版地区：UNITED STATES
是否预警：否
出版商：American Society of Hematology
出版周期：Semimonthly
创刊时间：1946
开源占比：0.1201
Gold OA文章占比：26.77%
OA被引用占比：0.0086...
出版国人文章占比：0.04
出版撤稿占比：0
研究类文章占比：86.54%

Blood CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

23.6

5.272

3.149

学科类别	分区	排名	百分位
大类：Biochemistry, Genetics and Molecular Biology 小类：Biochemistry	Q1	11 / 438	97%
大类：Biochemistry, Genetics and Molecular Biology 小类：Hematology	Q1	6 / 137	95%
大类：Biochemistry, Genetics and Molecular Biology 小类：Cell Biology	Q1	18 / 285	93%
大类：Biochemistry, Genetics and Molecular Biology 小类：Immunology	Q1	18 / 236	92%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Blood中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	1区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	1区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	1区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	1区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	1区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	HEMATOLOGY 血液学	1区

Blood JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：HEMATOLOGY	SCIE	Q1	2 / 97	98.5%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：HEMATOLOGY	SCIE	Q1	4 / 97	96.39%

Blood历年数据统计

影响因子

中科院分区

Blood中国学者发文选摘

1、PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371
Author: Chen, Hongxia; Bai, Yunpeng; Kobayashi, Michihiro; Xiao, Shiyu; Cai, Wenjie; Barajas, Sergio; Chen, Sisi; Miao, Jinmin; Meke, Frederick Nguele; Vemula, Sasidhar; Ropa, James P.; Croop, James M.; Boswell, H. Scott; Wan, Jun; Jia, Yuzhi; Liu, Huiping; Li, Loretta S.; Altman, Jessica K.; Eklund, Elizabeth A.; Ji, Peng; Tong, Wei; Band, Hamid; Huang, Danny T.; Platanias, Leonidas C.; Zhang, Zhong-Yin; Liu, Yan

Journal: BLOOD. 2023; Vol. 141, Issue 3, pp. 244-259. DOI: 10.1182/blood.2022016580
2、Human genetic defects in SRP19 and SRPRA cause severe congenital neutropenia with distinctive proteome changes
Author: Linder, Monika I.; Mizoguchi, Yoko; Hesse, Sebastian; Csaba, Gergely; Tatematsu, Megumi; Lyszkiewicz, Marcin; Zietara, Natalia; Jeske, Tim; Hastreiter, Maximilian; Rohlfs, Meino; Liu, Yanshan; Grabowski, Piotr; Ahomaa, Kaarin; Maier-Begandt, Daniela; Schwestka, Marko; Pazhakh, Vahid; Isiaku, Abdulsalam I.; Miranda, Brenda Briones; Blombery, Piers; Saito, Megumu K.; Rusha, Ejona; Alizadeh, Zahra; Pourpak, Zahra; Kobayashi, Masao; Rezaei, Nima; Unal, Ekrem; Hauck, Fabian; Drukker, Micha; Walzog, Barbara; Rappsilber, Juri; Zimmer, Ralf; Lieschke, Graham J.; Klein, Christoph

Journal: BLOOD. 2023; Vol. 141, Issue 6, pp. 645-658. DOI: 10.1182/blood.2022016783
3、C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse
Author: Yang, Li-Xue; Zhang, Cheng-Tao; Yang, Meng-Ying; Zhang, Xue-Hong; Liu, Hong-Chen; Luo, Chen -Hui; Jiang, Yue; Wang, Zhang-Man; Yang, Zhong-Yin; Shi, Zhao -Peng; Yang, Yi-Ci; Wei, Ruo-Qu; Zhou, Li; Mi, Jun; Zhou, Ai -Wu; Yao, Zhi-Rong; Xia, Li; Yan, Jin-Song; Lu, Ying

Journal: BLOOD. 2023; Vol. 141, Issue 7, pp. 766-786. DOI: 10.1182/blood.2022017046.
4、Cloned antibodies from patients with HIT provide new clues to HIT pathogenesis
Author: Zhu, Wen; Zheng, Yongwei; Yu, Mei; Wu, Yaling; Wei, Jianhui; Zhou, Lu; Fu, Guoping; Schneider, Nicholas; Jones, Curtis; Irani, Mehraboon; Padmanabhan, Anand; Aster, Richard; Wang, Demin; Wen, Renren

Journal: BLOOD. 2023; Vol. 141, Issue 9, pp. 1060-1069. DOI: 10.1182/blood.2022017612
5、A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis
Author: Yu, Xiaoliang; Ma, Haikuo; Li, Bohan; Ji, Yuting; Du, Yayun; Liu, Siying; Li, Zhanhui; Hao, Yongjin; Tian, Sheng; Zhao, Cong; Du, Qian; Jin, Zhongqin; Zhu, Xueming; Tian, Yuanyuan; Chen, Xin; Sun, Xue; Yang, Chengkui; Zhu, Fang; Ju, Jie; Zheng, Yunjing; Zhang, Wei; Wang, Jingrui; Yang, Tao; Wang, Xinhui; Li, Jingjing; Xu, Xiangping; Du, Shujing; Lu, Haohao; Ma, Feng; Zhang, Haibing; Zhang, Yi; Zhang, Xiaohu; Hu, Shaoyan; He, Sudan

Journal: BLOOD. 2023; Vol. 141, Issue 9, pp. 1070-1086. DOI: 10.1182/blood.2022017262
6、Fecal microbiota transplantation from young mice rejuvenates aged hematopoietic stem cells by suppressing inflammation
Author: Zeng, Xiangjun; Li, Xiaoqing; Li, Xia; Wei, Cong; Shi, Ce; Hu, Kejia; Kong, Delin; Luo, Qian; Xu, Yulin; Shan, Wei; Zhang, Meng; Shi, Jimin; Feng, Jingjing; Han, Yingli; Huang, He; Qian, Pengxu

Journal: BLOOD. 2023; Vol. 141, Issue 14, pp. 1691-1707. DOI: 10.1182/blood.2022017514
7、Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy.
Author: Kusumoto S¹, Arcaini L^2,³, Hong X⁴, Jin J⁵, Kim WS⁶, Kwong YL⁷, Peters MG⁸, Tanaka Y⁹, Zelenetz AD^10,¹¹, Kuriki H¹², Fingerle-Rowson G¹³, Nielsen T¹³, Ueda E¹², Piper-Lepoutre H¹³, Sellam G¹³, Tobinai K¹⁴.

Journal: Blood. 2019 Jan 10;133(2):137-146. doi: 10.1182/blood-2018-04-848044. Epub 2018 Oct 19.
8、The transmembrane protein disulfide isomerase TMX1 negatively regulates platelet responses.
Author: Zhao Z¹, Wu Y^1,², Zhou J^1,², Chen F¹, Yang A¹, Essex DW².

Journal: Blood. 2019 Jan 17;133(3):246-251. doi: 10.1182/blood-2018-04-844480. Epub 2018 Nov 13.